Edwards Lifesciences Corp

XNYS:EW 4:00:00 PM EDT

81.39

+1.66 (+2.08%)

: $81.03 -0.36 (-0.44%)

Market Cap (Intraday)	47.84B
Current PE	44.48
Forward PE	27.04
2yr Forward PE	24.15

See more stats

Estimates Current Quarter

Revenue	$1.7 Billion
Adjusted EPS	$0.74

See more estimates

10-Day MA	$81.11
50-Day MA	$81.61
200-Day MA	$81.20

See more pivots

Edwards Lifesciences Corp Stock, XNYS:EW

1 Edwards Way, Irvine, California 92614

United States of America

Phone: +1.949.250.2500

Number of Employees: 15800

http://www.edwards.com

Description

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.